Gastrointestinal Cancer: Targets and Therapy
Volume 4, 2014 - Issue
Open access
75
Views
0
CrossRef citations to date
0
Altmetric
Review
New developments in management of gastrointestinal stromal tumors: regorafenib, the new player in the team
Sergei Boichuk1 Cancer Virology Program, University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA;2 Department of Pathology, Kazan State Medical University, Kazan, Russia
, Jessica L Rausch1 Cancer Virology Program, University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA
& Anette Duensing1 Cancer Virology Program, University of Pittsburgh Cancer Institute, Hillman Cancer Center, Pittsburgh, PA, USA;3 Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USACorrespondence[email protected]
Pages 1-10
|
Published online: 12 Dec 2013
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.